End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
0.018 AUD | -5.26% | 0.00% | -10.00% |
04-30 | Transcript : Syntara Limited, Q3 2024 Earnings Call, Apr 30, 2024 | |
04-10 | Syntara Reaches 50% Recruitment in Phase 2 Trial for Bone Marrow Cancer Treatment | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
Quarterly revenue - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-10.00% | 14.27M | |
+37.74% | 723B | |
+34.25% | 595B | |
-2.07% | 369B | |
+20.25% | 332B | |
+2.99% | 282B | |
+17.09% | 244B | |
+9.65% | 208B | |
-4.79% | 205B | |
+2.81% | 168B |
- Stock Market
- Equities
- SNT Stock
- News Syntara Limited
- Pharmaxis Receives AU$5 Million R&D Tax Rebate